DK108725C - Fremgangsmåde til fremstilling af 5-substituerede 3-aminopyrazoler eller N-acylderivater eller kvaternære ammoniumforbindelser eller salte deraf. - Google Patents

Fremgangsmåde til fremstilling af 5-substituerede 3-aminopyrazoler eller N-acylderivater eller kvaternære ammoniumforbindelser eller salte deraf.

Info

Publication number
DK108725C
DK108725C DK31962AA DK31962A DK108725C DK 108725 C DK108725 C DK 108725C DK 31962A A DK31962A A DK 31962AA DK 31962 A DK31962 A DK 31962A DK 108725 C DK108725 C DK 108725C
Authority
DK
Denmark
Prior art keywords
aminopyrazoles
salts
substituted
preparation
quaternary ammonium
Prior art date
Application number
DK31962AA
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH77061A external-priority patent/CH401071A/de
Priority claimed from CH824061A external-priority patent/CH426844A/de
Priority claimed from CH1059861A external-priority patent/CH448104A/de
Application filed by Ciba Geigy filed Critical Ciba Geigy
Application granted granted Critical
Publication of DK108725C publication Critical patent/DK108725C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK31962AA 1961-01-24 1962-01-23 Fremgangsmåde til fremstilling af 5-substituerede 3-aminopyrazoler eller N-acylderivater eller kvaternære ammoniumforbindelser eller salte deraf. DK108725C (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH77061A CH401071A (de) 1961-01-24 1961-01-24 Verfahren zur Herstellung neuer Aminopyrazole
CH430561 1961-04-12
CH824061A CH426844A (de) 1961-01-24 1961-07-13 Verfahren zur Herstellung neuer Aminopyrazole
CH1059861A CH448104A (de) 1963-01-11 1961-09-13 Verfahren zur Herstellung neuer Aminopyrazole
CH1327461 1961-11-15

Publications (1)

Publication Number Publication Date
DK108725C true DK108725C (da) 1968-02-05

Family

ID=27508888

Family Applications (1)

Application Number Title Priority Date Filing Date
DK31962AA DK108725C (da) 1961-01-24 1962-01-23 Fremgangsmåde til fremstilling af 5-substituerede 3-aminopyrazoler eller N-acylderivater eller kvaternære ammoniumforbindelser eller salte deraf.

Country Status (5)

Country Link
US (1) US3169966A (da)
DE (3) DE1224746B (da)
DK (1) DK108725C (da)
FR (1) FR1334957A (da)
GB (1) GB937732A (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1252435A (da) * 1968-02-02 1971-11-03
US4347251A (en) * 1981-07-13 1982-08-31 American Cyanamid Company Novel 3-substituted amino-1-substituted heteroaryl-2-pyrazolines
EP0070376A1 (en) * 1981-07-13 1983-01-26 American Cyanamid Company Heterocyclic substituted-amino-pyrazolines
US4407803A (en) * 1981-08-17 1983-10-04 Abbott Laboratories Antiinflammatory 1-(quinolinyl)-2-pyrazoline derivatives
DE3132915A1 (de) * 1981-08-20 1983-03-03 Kali-Chemie Pharma Gmbh, 3000 Hannover 1,5-diphenylpyrazolin-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3442860A1 (de) * 1984-11-24 1986-05-28 Kali-Chemie Pharma Gmbh, 3000 Hannover 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3- on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2707295A1 (fr) * 1993-06-07 1995-01-13 Rhone Poulenc Agrochimie Fongicides pyrazoles substitués en position 3 par un hétérocycle.
DE60204633T2 (de) 2001-07-05 2006-06-14 Pfizer Prod Inc Sulfonyl-Heteroaryl-Triazole als entzündungshemmende und analgetische Mittel
US20040209897A1 (en) * 2002-12-20 2004-10-21 Pharmacia Corporation Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
CN101184487B (zh) * 2005-03-31 2010-11-03 詹森药业有限公司 作为抗菌剂的二环吡唑化合物
WO2012003405A1 (en) 2010-06-30 2012-01-05 Ironwood Pharmaceuticals, Inc. Sgc stimulators
AU2011326241B2 (en) 2010-11-09 2016-11-17 Ironwood Pharmaceuticals, Inc. sGC stimulators
CA2861804C (en) 2011-12-27 2021-10-26 Ironwood Pharmaceuticals, Inc. 2-benzyl,3(pyrimidin-2-yl)substituted pyrazoles useful as sgc stimulators
WO2014060381A1 (de) * 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2903460A (en) * 1956-04-07 1959-09-08 Sandoz Ag Pyrazolone derivatives
US2833779A (en) * 1956-10-29 1958-05-06 American Cyanamid Co Substituted pyrazoles
US3041343A (en) * 1959-10-14 1962-06-26 Sandoz Ltd 4-(thienyl-2'')-and 4-(pyridyl-3'')-5-aminopyrazoles

Also Published As

Publication number Publication date
DE1224746B (de) 1966-09-15
GB937732A (en) 1963-09-25
DE1231248B (de) 1966-12-29
FR1334957A (fr) 1963-08-16
DE1223394B (de) 1966-08-25
US3169966A (en) 1965-02-16

Similar Documents

Publication Publication Date Title
DK108725C (da) Fremgangsmåde til fremstilling af 5-substituerede 3-aminopyrazoler eller N-acylderivater eller kvaternære ammoniumforbindelser eller salte deraf.
DK103186C (da) Fremgangsmåde til fremstilling af alkoxypiperidinderivater eller salte deraf.
DK120902B (da) Analogifremgangsmåde til fremstilling af substituerede N-methylhydrazinforbindelser eller salte deraf.
DK106861C (da) Fremgangsmåde til fremstilling af basiske dibenzotiepinderivater eller deres salte eller kvaternære ammoniumforbindelser.
DK105478C (da) Fremgangsmåde til fremstilling af N-substituerede phenylethanolaminderivater eller salte deraf.
DK105469C (da) Fremgangsmåde til fremstilling af imidazolderivater eller salte deraf.
DK118822B (da) Analogifremgangsmåde til fremstilling af phenthiazin- eller 4-azaphenthiazinderivater eller salte eller kvaternære ammoniumderivater heraf.
DK92644C (da) Fremgangsmåde til fremstilling af basisk substituerede pyrrolidonforbindelser eller salte deraf.
DK102963C (da) Fremgangsmåde til fremstilling af uracilderivater eller salte deraf.
DK105813C (da) Fremgangsmåde til fremstilling af basiske thiophenderivater eller salte eller kvaternære ammoniumforbindelser deraf.
DK103022C (da) Fremgangsmåde til fremstilling af (N-R-aza-alkylenimino-alkyl-guanidiner eller kvaternære ammoniumforbindelser eller salte deraf.
DK102908C (da) Fremgangsmåde til fremstilling af derivater af tetrahydrodibenzocyloocten eller salte deraf.
DK100237C (da) Fremgangsmåde til fremstilling af 4-azaphenthiaziner eller salte eller kvaternære ammoniumforbindelser heraf.
DK100236C (da) Fremgangsmåde til fremstilling af 4-azaphenthiaziner eller salte eller kvaternære ammoniumforbindelser heraf.
DK99407C (da) Fremgangsmåde til fremstilling af azaphenthiazinderivater eller salte eller kvartære ammoniumforbindelser deraf.
DK104176C (da) Fremgangsmåde til fremstilling af hydrazinderivater eller salte eller kvaternære ammoniumforbindelser heraf.
DK98124C (da) Fremgangsmåde til fremstilling af umættede dibenzocycloheptanderivater eller salte eller kvarternære ammoniumforbindelser heraf.
DK97031C (da) Fremgangsmåde til fremstilling af phthalimidinforbindelser eller salte eller kvaternære ammoniumforbindelser deraf.
DK96983C (da) Fremgangsmåde til fremstilling af phthalimidinforbindelser eller salte eller kvaternære ammoniumforbindelser deraf.
DK101861C (da) Fremgangsmåde til fremstilling af substituerede triphenylcarbinolforbindelser eller salte eller kvaternære ammoniumforbindelser deraf.
DK96290C (da) Fremgangsmåde til fremstilling af estere af N-(hydroksyalkyl)-nortropaner eller -norgranataner eller salte eller kvaternære ammoniumforbindelser heraf.
DK105590C (da) Fremgangsmåde til fremstilling af N-acylderivater af kernerne af Cephalosporin C, Cephalosporin CC og Cephalosporin-CA-forbindelser eller salte deraf.
DK100616C (da) Fremgangsmåde til fremstilling af 4-phenylamino-quinolinderivater eller salte deraf.
DK104518C (da) Fremgangsmåde til fremstilling af 2-sulfanilamidopyrimidinderivater eller salte deraf.
DK102631C (da) Fremgangsmåde til fremstilling af phenylalkanolaminderivater eller salte deraf.